background
bovin
respiratori
syncyti
viru
brsv
import
respiratori
pathogen
worldwid
detriment
affect
economi
anim
welfar
prevent
control
brsv
infect
knowledg
viru
shed
transmiss
potenti
individu
anim
requir
studi
aim
detect
viral
rna
infect
virion
brsv
infect
evalu
durat
transmiss
period
correl
clinic
sign
diseas
outcom
brsv
reexposur
calv
hous
environ
effect
introduct
sentinel
calv
also
investig
live
anim
experi
includ
calv
conduct
day
initi
two
calv
inocul
nonpassag
brsv
field
isol
two
day
later
six
calv
eg
expos
group
introduc
commingl
four
week
later
anoth
two
calv
sg
sentinel
group
introduc
seven
week
commingl
eg
anim
reinocul
clinic
examin
perform
daili
nasal
swab
collect
regularli
analys
viral
rna
rtddpcr
viru
isol
perform
cell
cultur
brsv
serolog
perform
elisa
result
eg
calv
seroconvert
show
clinic
sign
respiratori
diseas
viral
rna
detect
day
exposur
infect
viru
isol
day
day
anim
seroposit
viru
could
isol
total
clinic
score
respiratori
sign
correspond
well
shed
viral
rna
sg
anim
introduc
day
exposur
remain
neg
brsv
rna
stay
seroneg
throughout
studi
inocul
eg
calv
seven
week
primari
infect
lead
new
shed
viral
rna
clinic
sign
diseas
conclus
viral
rna
detect
nasal
swab
calv
four
week
exposur
detect
amount
viral
rna
correspond
well
degre
respiratori
sign
calv
shed
infect
virion
consider
shorter
period
calv
introduc
four
week
infect
infect
calv
protect
reinfect
least
seven
week
knowledg
use
prevent
spread
brsv
bovin
respiratori
syncyti
viru
brsv
import
respiratori
pathogen
cattl
detriment
affect
economi
anim
welfar
viru
distribut
worldwid
major
pathogen
bovin
respiratori
diseas
complex
viral
respiratori
infect
also
concern
regard
antibiot
resist
predispos
cattl
secondari
bacteri
infect
commonli
treat
antibiot
bovin
respiratori
diseas
tradit
handl
manag
measur
vaccin
metaphylact
antibiot
treatment
anoth
possibl
strategi
prevent
interherd
transmiss
main
pathogen
increas
biosecur
measur
herd
level
live
anim
transport
consid
one
main
mode
brsv
transmiss
herd
proper
mitig
must
ensur
live
anim
transport
perform
without
compromis
biosecur
requir
knowledg
transmiss
risk
associ
anim
contact
differ
stage
infect
knowledg
brsv
shed
relat
clinic
featur
would
also
use
order
assess
transmiss
risk
infect
herd
without
use
viral
diagnost
assay
area
sever
knowledg
gap
exist
although
way
infect
may
affect
viral
shed
clinic
sign
compar
natur
expos
anim
challeng
studi
superior
sens
aetiolog
time
exposur
known
clinic
featur
viru
excret
follow
close
challeng
studi
mani
aim
evalu
efficaci
vaccin
seldom
last
longer
one
two
week
grissett
et
al
gershwin
conclud
shed
brsv
begin
day
three
four
postinfect
pi
usual
last
day
nine
ten
grissett
et
al
summar
median
time
appear
peak
resolut
clinic
sign
day
respect
base
inform
inocul
studi
studi
outlast
acut
phase
infect
lack
known
long
anim
transmit
infecti
virus
anim
appear
clinic
sign
usual
inform
avail
field
find
clinic
paramet
indic
shed
infecti
brsv
would
valuabl
exist
chronic
persist
infect
individu
likewis
still
unclear
acut
phase
brsv
infect
immunolog
protect
develop
assum
shortliv
might
enabl
earli
reinfect
new
shed
infect
viru
complic
risk
assess
brsv
studi
perform
shed
light
studi
kimman
et
al
report
strong
local
iga
respons
respiratori
tract
viru
shed
calv
reexpos
month
primari
brsv
infect
stott
et
al
indic
refer
unpublish
result
reinfect
calv
heifer
may
occur
earli
three
week
postinfect
howev
earli
reinfect
brsv
welldocu
precis
knowledg
occurr
need
exist
literatur
brsv
shed
transmiss
base
variou
laboratori
method
detect
viral
rna
cultur
viru
although
resourcedemand
viru
transmiss
studi
prefer
perform
use
live
anim
sentinel
trial
aim
present
studi
therefor
studi
basic
featur
brsv
infect
calv
infect
exposur
brsvshed
calv
perform
descript
live
anim
experi
total
calv
perform
experiment
unit
group
calv
total
experiment
period
day
calv
euthan
end
experi
group
design
inocul
group
ig
calf
expos
group
eg
calf
e
e
sentinel
group
sg
calf
intervent
ig
inocul
brsv
eg
exposur
ig
acut
stage
day
challeng
inocul
brsv
intervent
sg
exposur
eg
environ
day
first
exposur
brsv
readout
presenc
brsv
rna
infect
brsv
antibrsv
antibodi
clinic
sign
weight
gain
patholog
lesion
singl
anim
use
control
mainli
detect
whether
calv
clinic
healthi
averag
weight
gain
antibodi
relev
respiratori
virus
brsv
bcov
exposur
brsv
experi
perform
openlabel
trial
blind
practic
achiev
timelin
experiment
period
overview
intervent
provid
fig
experi
conduct
laboratori
anim
unit
norwegian
veterinari
institut
oslo
facil
consist
three
hous
unit
separ
ventil
system
separ
entranc
sluic
room
sluic
cloth
boot
personnel
chang
hand
wash
routin
entranc
calv
unit
provid
separ
equip
care
sampl
one
freerang
hous
pen
ad
libitum
water
suppli
pen
bed
sawdust
clean
manual
technician
day
pen
ig
inocul
two
pen
roughag
fed
ad
libitum
commerci
concentr
formula
allot
twice
day
allot
concentr
start
kg
per
day
gradual
increas
kg
within
first
three
week
three
week
throughout
studi
period
ration
stabl
kg
per
day
ten
brsv
seroneg
convent
rear
wean
norwegian
red
calv
age
month
includ
two
heifer
eight
bull
calv
obtain
three
privat
norwegian
dairi
farm
situat
southeastern
part
norway
proxim
facil
alloc
anim
experiment
group
random
except
calv
differ
age
mix
avoid
age
bia
first
eight
calv
initi
hous
three
differ
room
acclimat
period
two
ig
calv
room
inocul
brsv
experi
two
day
later
move
room
respect
hold
three
eg
calv
eg
calv
hous
togeth
ig
calv
euthan
brought
room
respect
eg
calv
hous
two
sg
calv
move
separ
room
room
time
eg
calv
rearrang
induc
mild
stress
two
three
calv
room
move
room
rechalleng
inocul
brsv
move
back
room
respect
remain
eight
calv
euthan
prior
inocul
brsv
field
isol
earlier
describ
klem
et
al
centrifug
x
g
filter
filter
exclud
possibl
bacteri
contamin
filtrat
seed
blood
agar
plate
cultur
h
filtrat
also
test
rtpcr
presenc
brsv
bovin
viru
bovin
corona
viru
bcov
inhous
method
norwegian
veterinari
institut
oslo
norway
filtrat
posit
brsv
ctvalu
neg
bcov
bacteria
inoculum
prepar
dilut
filtrat
steril
nacl
inocul
procedur
perform
nonsed
calv
via
manual
restraint
head
kept
horizont
posit
ml
inoculum
nebul
intranas
use
perfor
plastic
tube
diamet
mm
inner
channel
mm
tube
insert
cm
left
nostril
nebul
left
nostril
close
hand
avoid
outflow
inoculum
moder
sever
depress
calv
high
respiratori
rate
temperatur
treat
mgkg
meloxicam
pain
relief
antiinflammatori
effect
bacteri
pneumonia
suspect
mgkg
procain
benzylpenicillin
administ
im
daili
five
day
euthanasia
perform
stun
captiv
bolt
follow
bleedout
qualifi
personnel
monitor
calv
morn
even
frequent
deem
necessari
veterinarian
examin
calv
daili
basi
three
four
time
week
thereaft
throughout
experiment
period
gener
health
condit
calv
neg
affect
frequenc
examin
increas
clinic
score
system
develop
modifi
et
al
present
tabl
overal
clinic
score
calcul
sum
separ
score
clinic
registr
peak
outbreak
defin
day
highest
number
clinic
affect
calv
collect
blood
sampl
nasal
swab
perform
three
four
time
week
anim
nasal
swab
copan
brescia
itali
viru
detect
place
approxim
five
cm
right
left
nostril
altern
swab
press
gentli
nasal
septum
roll
four
time
swab
kept
ice
store
within
one
hour
analysi
blood
collect
extern
jugular
vein
plain
tube
sera
store
analysi
nasal
swab
collect
experiment
period
analys
rna
extract
swab
transport
medium
use
autom
nuclisen
easymag
protocol
marci
letoil
franc
accord
manufactur
instruct
quantif
brsv
genom
conduct
duplic
biorad
ddpcr
system
droplet
digit
pcr
run
includ
posit
rna
nostril
brsvposit
trial
calf
neg
control
water
droplet
gener
transfer
droplet
describ
manufactur
onestep
rtddpcr
advanc
kit
probe
biorad
ca
usa
rna
use
sequenc
primer
probe
fam
quencher
describ
boxu
et
al
target
bp
region
brsv
n
gene
primer
probe
concentr
recommend
kit
manufactur
follow
cycl
condit
min
min
cycl
min
ramp
rate
set
data
process
absolut
quantif
brsv
genom
per
rna
perform
quantasoft
version
biorad
ca
usa
posit
nasal
swab
calv
subject
kaplanmei
surviv
analysi
stata
stata
se
stata
corp
colleg
station
tx
usa
function
show
cumul
surviv
ie
shed
brsv
rna
time
decreas
nasal
swab
calv
turn
brsv
rna
neg
exact
timepoint
nasal
swab
calf
turn
neg
unknown
midpoint
last
posit
follow
neg
sampl
use
analysi
base
rtddpcr
result
nasal
swab
select
viru
isol
three
differ
time
point
calv
group
eg
second
day
calv
test
posit
viral
rna
calv
still
posit
first
day
viral
rna
longer
detect
eg
calv
five
six
posit
viru
isol
perform
inocul
foetal
bovin
turbin
fbt
cell
propag
eagl
minim
essenti
medium
emem
belgium
well
plate
duplic
sampl
filter
nasal
swab
medium
min
ad
medium
fc
neg
replic
control
cell
harvest
parallel
sampl
incub
co
cell
observ
cytopathogen
effect
cpe
passag
day
incub
presenc
cpe
confirm
direct
immunofluoresc
test
use
fitc
moab
abrsv
biox
diagnost
rochefort
belgium
supernat
test
brsv
rtddpcr
describ
indirect
elisa
detect
serum
antibodi
specif
brsv
brsvab
bcov
bcvab
svanova
biotech
ab
uppsala
sweden
perform
accord
manufactur
instruct
sera
collect
calv
everi
second
day
analys
brsv
antibodi
addit
sera
analys
detect
antibodi
bcov
specif
time
point
ig
eg
sg
standard
postmortem
examin
perform
infect
anim
ig
eg
includ
macroand
micropatholog
examin
respiratori
tissu
lung
tissu
prepar
cultur
presenc
bacteria
section
stain
haematoxylineosin
histolog
investig
calv
weigh
two
three
time
per
week
throughout
experiment
period
averag
daili
weight
gain
calcul
infect
anim
ig
eg
divid
total
weight
gain
number
day
weigh
median
averag
daili
weight
gain
calv
calcul
minimum
min
maximum
max
median
valu
regist
acclimat
period
peak
infect
period
restitut
period
ig
eg
calv
show
sign
respiratori
diseas
vari
mild
sever
tabl
ig
first
clinic
sign
observ
three
day
inocul
one
calf
spars
serou
nasal
discharg
four
day
later
inocul
anim
show
mild
respiratori
sign
mild
depress
normal
seromuc
nasal
discharg
sporad
cough
nine
day
inocul
total
clinic
score
highest
ig
calv
median
total
clinic
score
valu
first
clinic
sign
appear
three
six
eg
calv
show
mild
sign
respiratori
diseas
includ
sporad
cough
mild
depress
andor
spars
serou
mildli
opaqu
nasal
discharg
calv
e
e
start
show
sever
sign
respiratori
diseas
respect
qualifi
medic
treatment
penicillin
antiinflammatori
drug
associ
brsv
rtddpcr
result
versu
score
clinic
paramet
total
clinic
score
eg
calv
shown
fig
brsv
rna
detect
nasal
swab
ig
eg
calv
first
challeng
quantit
rna
valu
given
tabl
ig
first
posit
sampl
detect
two
day
inocul
eg
rna
first
detect
anim
posit
peak
one
ig
calf
posit
two
eg
calv
still
posit
nasal
swab
calv
neg
respect
log
number
genom
copi
found
tabl
result
kaplanmeiersurviv
analysi
viral
rna
nasal
swab
calv
provid
fig
accord
analysi
estim
longest
persist
viral
rna
day
exposur
sg
calv
neg
viral
rna
throughout
studi
period
none
eg
calv
posit
follow
rechalleng
cytopathogen
effect
posit
immunostain
observ
cell
incub
swab
materi
six
eg
calv
collect
clear
cpe
immunostain
caus
sampl
collect
high
differ
supernat
viral
rna
titer
found
rtddpcr
neg
replic
control
incub
sampl
rang
log
gc
per
swab
respect
sampl
collect
show
rise
supernat
viral
rna
titer
two
passag
fbt
cell
indic
infect
brsv
calv
test
neg
antibodi
brsv
inoculationexposur
ig
one
calf
seroconvert
calv
posit
eg
calv
seroconvers
first
detect
tabl
log
number
genom
copi
brsv
per
swab
calv
inocul
group
ig
calf
expos
group
eg
calf
e
e
first
day
exposur
ig
eg
last
day
nasal
swab
posit
viral
rna
detect
ddpcr
day
postexposur
eg
log
genom
copi
brsvswab
ig
eg
calv
calv
seroconvert
sg
calv
remain
seroneg
brsv
throughout
studi
period
fig
correspond
median
valu
eg
brsv
antibodi
titer
rna
quantiti
present
anim
seroconvert
toward
bcov
ig
eg
anim
mild
patholog
lesion
respiratori
tract
bronchointerstiti
pneumonia
rang
mild
moder
five
eight
calv
mucopurul
bronchiti
andor
bronchiol
six
mild
bronchiol
obliteran
seven
mild
pronounc
atelectasi
one
calf
pleuriti
calv
mild
pronounc
bronchusassoci
lymphoid
tissu
hyperplasia
mild
moder
reactiv
hyperplasia
lymphat
tissu
nasopharynx
region
lymph
node
lung
bacteri
cultur
lung
tissu
show
growth
except
one
calf
spars
occurr
trueperella
pyogen
identifi
acclimat
period
median
averag
daili
weight
gain
calv
g
min
g
max
g
peak
infect
period
reduc
g
min
g
max
g
increas
g
min
max
g
restitut
period
present
studi
aim
assess
transmiss
potenti
brsv
infect
calv
hous
environ
experiment
set
ten
anim
includ
studi
although
ideal
chosen
studi
design
common
experiment
infect
studi
larg
anim
contrast
type
studi
tradit
laboratori
anim
epidem
studi
eg
natur
infect
field
sever
challeng
relat
larg
size
anim
like
access
experiment
facil
accept
size
biosecur
level
also
econom
aspect
due
high
cost
hous
experiment
facil
cost
purchas
calv
ethic
aspect
accord
number
anim
use
alway
concern
consequ
present
studi
perform
descript
experiment
infect
studi
experiment
set
allow
control
condit
control
time
exposur
brsv
difficult
achiev
field
condit
natur
condit
mimick
concern
host
speci
age
breed
feed
social
interact
calv
sever
environment
factor
calv
identifi
risk
factor
respiratori
diseas
among
low
temperatur
combin
wet
anim
dust
herd
size
transport
share
hous
calv
adult
cattl
larg
differ
age
commingl
mani
calv
pen
present
experi
factor
advis
possibl
implement
mild
stressor
introduc
move
anim
commingl
calv
ie
rearrang
experi
bed
dri
leav
anim
room
dustier
averag
herd
although
sever
respiratori
diseas
observ
clinic
symptom
might
even
sever
viru
introduc
regular
cattl
herd
nonpassag
brsv
strain
obtain
field
outbreak
respiratori
diseas
use
inocul
order
avoid
chang
virul
due
cultiv
cell
line
main
calf
group
eg
natur
exposur
virusshed
calv
use
mimic
field
condit
experiment
studi
usual
includ
control
group
anim
kept
environ
howev
due
biosecur
measur
room
capac
present
hous
facil
allow
therefor
calf
function
control
use
period
prior
challeng
control
period
long
experiment
period
allow
studi
presenc
nasal
mucosaassoci
viral
rna
extend
time
period
reveal
brsv
present
four
week
start
compar
result
group
calv
investig
present
studi
previou
studi
conclud
viral
shed
usual
begin
later
last
shorter
period
studi
claim
brsv
replic
upper
respiratori
tract
occur
earli
stage
infect
led
conclus
sampl
bronchoalveolar
lavag
lung
tissu
necessari
diagnost
purpos
later
stage
diseas
present
result
indic
diagnost
sampl
use
nasal
swab
suitabl
one
month
exposur
brsv
line
anoth
studi
klem
et
al
enabl
easier
cheaper
frequent
test
anim
risk
although
viral
rna
found
nasal
swab
four
week
cell
cultur
propag
brsv
nasal
swab
indic
shed
period
infecti
viru
amount
consider
shorter
approx
day
indic
shorter
period
actual
transmiss
risk
two
sg
calv
remain
uninfect
commingl
eg
calv
environ
four
week
eg
calv
expos
brsv
number
calv
unfortun
low
conclud
would
valid
real
herd
larger
number
anim
nevertheless
would
interest
investig
studi
anim
includ
sequenti
studi
design
recent
experiment
infect
studi
bcov
similar
pattern
observ
rna
bcov
detect
approxim
month
infect
infect
viru
found
consider
shorter
last
day
result
suggest
strategi
appli
prevent
interherd
transmiss
bovin
respiratori
diseas
complex
pathogen
differ
found
viral
shed
pattern
eg
ig
calv
might
reflect
differ
infect
caus
natur
exposur
viru
artifici
inocul
procedureeg
time
exposur
detect
viral
rna
nasal
swab
shorter
eg
calv
time
inocul
viral
shed
ig
calv
viru
nasal
swab
might
reflect
presenc
inhal
viru
activ
brsv
infect
bovin
respiratori
syncyti
viru
labil
envelop
viru
freez
thaw
detriment
affect
infect
amount
infect
viru
unknown
inocul
may
contain
less
infect
viru
amount
eg
calv
expos
might
explain
inocul
led
longer
incub
period
less
sever
infect
ig
calv
addit
viral
rna
detect
longer
period
time
eg
calv
late
outbreak
peak
clinic
sign
eg
compar
earlier
report
experiment
infect
might
caus
prolong
process
group
anim
natur
expos
brsv
add
view
studi
base
natur
exposur
valid
inocul
studi
clinic
infect
resembl
natur
occur
brsv
infect
infect
calv
show
respiratori
sign
individu
differ
sever
comparison
median
valu
total
clinic
score
brsv
rna
titer
show
clear
conform
two
paramet
cours
trial
gener
detect
replic
viral
rna
occur
day
onset
clinic
sign
rise
temperatur
cough
commonli
use
measur
detect
respiratori
diseas
field
present
experi
paramet
increas
time
period
number
brsv
genom
copi
rais
howev
cough
continu
intermitt
much
longer
period
viral
rna
detect
median
valu
rectal
temperatur
score
slightli
elev
increas
respiratori
rate
nasal
discharg
appear
clinic
paramet
correspond
best
detect
viral
rna
includ
calv
clinic
sign
also
correspond
well
period
activ
brsv
infect
detect
approxim
three
week
infect
viru
could
isol
clinic
sign
mild
longer
present
patholog
examin
show
ig
eg
calv
mild
patholog
lesion
respiratori
tract
unexpect
calv
longer
clinic
ill
time
euthanasia
nevertheless
low
averag
daili
weight
gain
peak
infect
period
failur
regain
normal
growth
recoveri
period
agreement
previou
find
indic
neg
effect
growth
product
month
appar
recoveri
infect
calv
show
clinic
sign
patholog
chang
normal
associ
brsv
infect
calv
without
coinfect
howev
infect
brsv
known
predispos
cattl
secondari
bacteri
infect
despit
fact
bacteri
examin
lung
tissu
post
mortem
neg
calv
one
spars
number
trueperella
pyogen
possibl
complet
rule
possibl
coinfectionsespeci
consid
fact
experi
two
calv
medic
treat
penicillin
brsv
also
known
occur
coinfect
virus
mycoplasma
spp
present
studi
none
anim
infect
bcov
norwegian
cattl
popul
current
free
mani
intern
recogn
agent
bovin
respiratori
diseas
exampl
bovin
herp
viru
type
bovin
viral
diarrhoea
viru
mycoplasma
bovi
never
detect
calv
present
studi
reinfect
inocul
seven
week
primari
infect
indic
protect
immun
longer
previous
suggest
sentinel
anim
remain
seroneg
contact
eg
anim
one
month
onset
infect
seroconvers
eg
calv
two
three
week
coincid
period
activ
infect
clear
viru
longer
seem
infect
cell
cultur
taken
togeth
protect
immun
seem
correspond
detect
serum
antibodi
last
least
week
median
clinic
score
mean
viral
rna
detect
viru
infect
coincid
strongli
reduc
three
week
exposur
brsv
neg
result
sentinel
studi
support
argument
brsv
infect
anim
hous
environ
pose
lower
risk
three
four
week
combin
knowledg
registr
clinic
sign
respiratori
diseas
emphasi
occurr
increas
respiratori
rate
could
use
inform
implement
prevent
biosecur
measuressuch
period
quarantineto
avoid
spread
viru
howev
experiment
set
rel
anim
age
differ
transmiss
dynam
regular
herd
one
challeng
convent
herd
set
know
time
point
viru
circul
throughout
whole
herd
sinc
anim
may
develop
subclin
infect
time
point
last
anim
clear
infect
often
unknown
despit
effort
experi
mimic
natur
condit
factor
must
consid
result
appli
herd
studi
viral
brsv
rna
detect
nasal
swab
calv
day
exposur
viru
period
infect
virus
found
shorter
day
total
clinic
score
increas
respiratori
rate
nasal
discharg
correspond
best
shed
viral
rna
contact
eg
calv
calv
four
week
exposur
result
infect
eg
calv
protect
reinfect
seven
week
initi
exposur
add
basic
understand
transmiss
pattern
brsv
withinand
betweenherd
provid
support
prevent
action
use
design
interherd
biosecur
measur
